InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,698.46
(
-0.27%
)
US TECH 100
19,270.40
(
-0.33%
)
Dow Jones
42,011.78
(
-0.03%
)
Brent Oil
74.11
(
-0.29%
)
Bitcoin
62,938.92
(
-0.02%
)
Post# of 43360
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Fezziwig2008

Send PM Follow Ignore
Followers 24
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Fezziwig2008

Re: None

Monday, 10/19/2020 7:52:50 AM

Monday, October 19, 2020 7:52:50 AM

Post# of 43360
HGEN “Phase III may not be necessary for approval in ZUMA-19; precedent is CAR-Ts to date have been approved on Phase II data in
UK
US, EU, Australia
Australia”

So $GILD May start using Lenzilumab to add value and safety to Yescarta sooner after the acquisition of HGEN.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up